After prior rejection, Iterum nabs long-sought FDA nod for oral UTI drug Orlynvah
Despite recent concerns from the FDA about potential off-label use and antimicrobial resistance, Dublin-based Iterum Therapeutics has scored a green light for its oral antibiotic sulopenem. Sulopenem,...